A sertralina foi aprovada para as seguintes indicações: depressão maior, transtorno obsessivo-compulsivo, transtorno do stress pós-traumático, transtorno associado à tensão pré-menstrual, transtorno do pânico, distimia, fobia social, transtorno da ansiedade social e transtorno de ansiedade generalizada. No entanto, um considerável corpo de pesquisa posterior estabeleceu-a como uma das drogas de escolha para o tratamento da depressão em pacientes de ambulatório. Apesar dos resultados negativos nos ensaios iniciais, a sertralina é muitas vezes usada também para tratar pacientes internados. e para a distimia, uma condição menos severa e mais crônica de depressão. Em vários estudos duplo-cego, a sertralina foi, consistentemente, mais eficiente que o placebo, no que diz respeito à distimia A sertralina também trata a depressão em pacientes distímicos em um grau mais elevado em relação à terapia cognitivo-comportamental em grupo ou à psicoterapia interpessoal. Adicionando a psicoterapia à sertralina não se mostrou uma melhoria de resultados. O tratamento com sertralina de pacientes depressivos com transtorno de personalidade co-mórbido, melhorou os seus traços de personalidade e a sua melhoria foi praticamente independente das melhorias da sua depressão. tadalafil e20 pill The NICE British National Formulary (BNF) and British National Formulary for Children (BNFc) sites are only available to users in the UK, Crown Dependencies and British Overseas Territories. If you believe you are seeing this page in error please contact us. Doxycycline upper respiratory infection Clonidine price Levitra after eating Because sertraline is tightly bound to plasma protein, the administration of ZOLOFT sertraline hydrochloride to a patient taking another drug which is tightly. fluconazole diarrhea It is used to treat depression, panic disorder, and obsessive-compulsive disorder OCD. Sertraline works by affecting the balance of chemicals in the brain. These highlights do not include all the information needed to use ZOLOFT safely and effectively. See full prescribing information for ZOLOFT. ZOLOFT sertraline hydrochloride tablets, for oral use WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behavior in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors. In addition to the contraindications for all ZOLOFT formulations listed above, ZOLOFT oral solution is contraindicated in patients taking disulfiram. ZOLOFT oral solution contains alcohol, and concomitant use of ZOLOFT and disulfiram may result in a disulfiram-alcohol reaction. Serotonin Syndrome: Patients on ZOLOFT should be monitored for the emergence of a potentially life-threatening serotonin syndrome, particularly with concomitant use of serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John’s Wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue). If concomitant use of ZOLOFT with other serotonergic drugs is clinically warranted, inform patients of the increased risk of serotonin syndrome and monitor for symptoms. Initial: 50 mg q Day PO given continuously throughout menstrual cycle or given during luteal phase only May increase by 50 mg at the onset of each new menstrual cycle; no more than 150 mg q Day when administered continuously or 100 mg q Day when administered during luteal phase only 25 mg PO q Day initially; may increase by 25 mg every 2-3 days; not to exceed 200 mg q Day Alzheimer dementia related depression: Start at 12.5 mg/day and titrate every 1-2 weeks to response; not to exceed 150-200 mg Renal impairment: Dose adjustment not necessary Mild hepatic impairment (Child-Pugh 5-6): Decrease recommended starting dose and therapeutic dose by 50% Moderate-to-severe hepatic impairment (Child-Pugh 7-15): Not recommended; sertraline is extensively metabolized, and the effects in patients with moderate and severe hepatic impairment have not been studied Clinical worsening and suicide ideation may occur despite medication Use caution in patients with seizure disorders May worsen mania symptoms or precipitate mania in patients with bipolar disorder Increases risk of hyponatremia and impairment of cognitive/motor functions in the elderly Increases risk of bleeding in patients taking anticoagulants/antiplatelets concomitantly Risk of mydriasis; may trigger angle closure attack in patients with angle closure glaucoma with anatomically narrow angles without a patent iridectomy Pregnancy: Conflicting evidence regarding use of SSRIs during pregnancy and increased risk of persistent pulmonary hypertension of the newborn (see Pregnancy) In neonates exposed to SNRIs/SSRIs late in third trimester: Risk of complications such as feeding difficulties, irritability, and respiratory problems Avoid abrupt withdrawal Bone fractures reported with antidepressant therapy; consider the possibility if patient presents with bone pain, bruising, or point of tenderness Coadministration with other drugs that enhance the effects of serotonergic neurotransmission (eg, tryptophan, fenfluramine, fentanyl, 5-HT agonists, St. John’s Wort) should be undertaken with caution and avoided whenever possible due to the potential for pharmacodynamic interaction (see Contraindications) May cause false-positive urine immunoassay screening tests for benzodiazepines SSRIs and SNRIs are associated with development of SIADH; hyponatremia reported Several SSRIs (eg, fluoxetine, fluvoxamine, paroxetine, sertraline) are metabolized by CYP2D6 CYP2D6 is involved in the metabolism of approximately 20% of drugs in clinical use and displays large individual-to-individual variability in activity due to genetic polymorphisms More than 80 CYP2D6 variant alleles have been identified; however, 4 of the most prevalent alleles, CYP2D6*3, *4, *5, and *6, account for 93-97% of CYP2D6 poor metabolizers CYP2D6*4, the most common variant (~25% frequency in whites), causes a splicing defect; CYP2D6*3 (2.7% frequency) causes a frameshift mutation; and CYP3D6*5 (2.6%) is an entire deletion of the CYP2D6 gene; individuals homozygous for these alleles have no CYP2D6 activity The impact of CYP2D6 activity is further complicated in some SSRIs (eg, fluoxetine, fluvoxamine, paroxetine, sertraline) because in addition to being substrates for CYP2D6, they are also known to moderately inhibit CYP2D6 activity The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information. Sertraline contraindications Zoloft Sertraline Hcl Side Effects, Interactions, Warning, Dosage., Sertraline - Uses, Side Effects, Interactions - Where can i buy kamagra in uk Viagra on line no prec highest rated Buy propecia online hong kong Where to buy metformin weight loss Cialis 4 mg Sertraline, sold under the trade name Zoloft among others, is an antidepressant of the selective. 1.3 Panic disorder; 1.4 Other anxiety disorders; 1.5 Premenstrual dysphoric disorder; 1.6 Other indications. 2 Contraindications. 2.1 Pregnancy and lactation. Sertraline - Wikipedia Prescribing Information including BOXED WARNING Prescribing Information including BOXED Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for SERTRALINE. amoxicillin good for CONTRAINDICATIONS. ZOLOFT is contraindicated in patients Taking, or within 14 days of stopping, MAOIs, including the MAOIs linezolid and intravenous. Sertraline is contraindicated in patients with a hypersensitivity to sertraline or any. of sertraline within 14 days of stopping MAOI therapy is also contraindicated.